Morgan Stanley downgrades ABIOMED (Nasdaq: ABMD) from Overweight to Equalweight.

Shares of ABIOMED fell more than 23% yesterday following ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE